Screener Proficiency Testing Platform Global Market Report 2026

The screener proficiency testing platform market size has grown rapidly in recent years. It will grow from $1.24 billion in 2025 to $1.36 billion in 2026 at a compound annual growth rate (CAGR) of 10%. The growth in the historic period can be attributed to rising need for skill validation, adoption of manual proficiency testing, regulatory mandates for compliance, growth in healthcare and diagnostic labs, increased demand for standardized evaluation tools.

The screener proficiency testing platform market size is expected to see rapid growth in the next few years. It will grow to $2.01 billion in 2030 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to adoption of ai-driven evaluation, cloud-based proficiency platforms, expansion of training and certification programs, demand for real-time performance analytics, integration with enterprise quality management systems. Major trends in the forecast period include automated performance analytics, standardized test sample distribution, integration with laboratory information systems, regulatory compliance reporting, continuous skill improvement platforms.

The increasing use of diagnostic testing is expected to drive the growth of the screener proficiency testing platform market going forward. Diagnostic tests are medical procedures performed to detect, diagnose, or monitor diseases, conditions, or infections in patients. The heightened demand for diagnostic tests is largely fueled by growing awareness of the benefits of early disease detection, which allows for timely interventions and improved patient outcomes. Screener proficiency testing platforms support diagnostic testing by delivering standardized, high-quality assessment materials and performance evaluations for laboratories. They ensure accuracy, reliability, and adherence to regulatory requirements, reducing errors and enhancing overall diagnostic confidence and patient care. For instance, in December 2024, according to the National Health Service, a UK-based government department, the number of diagnostic tests conducted reached 2,544,809 in 2024, up from 2,312,030 in 2023. Therefore, the growing use of diagnostic testing is driving the expansion of the screener proficiency testing platform market.

Key companies operating in the screener proficiency testing platform market are focusing on unified artificial intelligence screening and workflow automation capabilities, such as diagnostic accreditation support programs, to enhance laboratory quality assurance, regulatory compliance readiness, analytical accuracy, and inter-laboratory performance standardization across clinical testing environments. Diagnostic accreditation support program refers to the structured introduction and implementation of organized initiatives designed to assist laboratories and diagnostic facilities in meeting accreditation standards. For example, in October 2025, the College of American Pathologists, a US-based professional organization of board-certified pathologists, launched 21 new Proficiency Testing (PT) and External Quality Assessment (EQA) programs for 2026, including the first globally available molecular program for HIV-1/HIV-2 detection and differentiation and the first US-based PT program for identifying the H5N1 avian influenza strain. These programs also feature novel offerings in microbiology, transfusion medicine, and instrumentation verification, along with a new Reticulocyte Calibration Verification and Linearity tool designed to detect analytical measurement range changes and improve diagnostic accuracy, reliability, and laboratory quality.

In June 2024, Simulations Plus Inc., a US-based pharmaceutical modeling and simulation software company, acquired Pro‑ficiency Holdings Inc. for around $100 million. Through this acquisition, Simulations Plus enhanced its platform capabilities across the drug development continuum by incorporating Pro‑ficiency’s simulation-enabled performance and intelligence solutions to improve clinical trial support, data analytics, and commercial launch training. Pro‑ficiency Holdings Inc. is a US-based technology company providing a simulation-based training and proficiency testing platform specializing in clinical trials and life sciences.

Major companies operating in the screener proficiency testing platform market are Thermo Fisher Scientific Inc., Merck KGaA, Waters Corporation, Bio-Rad Laboratories Inc., Randox Laboratories Ltd., LGC Limited, National Association of Testing Authorities, College of American Pathologists, Fera Science Limited, RCPA Quality Assurance Programs, UK NEQAS, American Proficiency Institute, Quality Control for Molecular Diagnostics, QACS Ltd., INSTAND e.V., ECAT Foundation, Weqas, Canadian External Quality Assessment Laboratory, Proficiency Testing Australia Pty Ltd., ANAB Proficiency Testing.

North America was the largest region in the screener proficiency testing platform market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the screener proficiency testing platform market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the screener proficiency testing platform market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The screener proficiency testing platform market consists of revenues earned by entities by providing services such as digital proficiency assessment programs, standardized screening simulations, performance benchmarking, compliance monitoring, and quality assurance analytics. The market value includes the value of related goods sold by the service provider or included within the service offering. The screener proficiency testing platform market includes sales of cloud-based testing software, performance analytics dashboards, automated scoring modules, reporting and certification tools, and data management systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

A screener proficiency testing platform is a digital solution designed to assess and validate the accuracy of individuals or automated systems involved in screening tasks. It offers standardized test samples, performance analytics, benchmarking tools, and compliance reporting to ensure consistent quality and reliability. These platforms support operational precision, regulatory compliance, and continuous improvement through data-driven evaluation.

The key components of screener proficiency testing platforms include software, services, and platforms. Software refers to digital tools that assess, track, and manage screener skills and performance across operational settings. They are deployed via cloud-based, on-premises, and hybrid models and are used by organizations of all sizes, including large enterprises and SMEs. Applications include performance evaluation, compliance monitoring, quality assurance, certification and accreditation, and benchmarking and analytics, serving hospitals and diagnostic laboratories, airport and transportation security agencies, government and regulatory bodies, customs and border protection agencies, manufacturing and quality control facilities, forensic science laboratories, and educational and training institutions.

Tariffs have affected the screener proficiency testing platform market by increasing costs for importing software modules, cloud infrastructure, and specialized services. This impact is most notable in software and platform segments, especially in regions like North America and Europe that rely on imported technology. While tariffs raise operational costs, they are encouraging local software development, promoting cost-effective cloud solutions, and driving innovation in automated evaluation platforms, ultimately supporting market adaptability.

The screener proficiency testing platform market research report is one of a series of new reports that provides screener proficiency testing platform market statistics, including screener proficiency testing platform industry global market size, regional shares, competitors with a screener proficiency testing platform market share, detailed screener proficiency testing platform market segments, market trends and opportunities, and any further data you may need to thrive in the screener proficiency testing platform industry. This screener proficiency testing platform market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.